Journal for ImmunoTherapy of Cancer (Nov 2020)
59 Integrating deep proteomics profiling with survival analysis to identify novel biomarkers of response to PD-1 blockade in NSCLC patients
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2020)